Basit öğe kaydını göster

Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections.

dc.contributor.authorMenekse, S.
dc.contributor.authorAydin, M.
dc.contributor.authorErgonul, O.
dc.contributor.authorAzap, A.
dc.contributor.authorBilgin, H.
dc.contributor.authorAydin, G.
dc.contributor.authorCavus, S. A.
dc.contributor.authorDemiroglu, Y. Z.
dc.contributor.authorAliskan, H. E.
dc.contributor.authorMemikoglu, O.
dc.contributor.authorKaya, S.
dc.contributor.authorDemir, N. A.
dc.contributor.authorKaraoglan, I.
dc.contributor.authorTezer, Y.
dc.contributor.authorDemirkaya, H.
dc.contributor.authorCakar, S. E.
dc.contributor.authorKeske, S.
dc.contributor.authorTekin, S.
dc.contributor.authorYardimci, C.
dc.contributor.authorKarakoc, C.
dc.contributor.authorBasaran, Seniha
dc.contributor.authorErgen, P.
dc.contributor.authorAzap, O.
dc.contributor.authorMulazimoglu, L.
dc.contributor.authorUral, O.
dc.contributor.authorCan, F.
dc.contributor.authorAkalin, H.
dc.contributor.authorYilmaz, E.
dc.contributor.authorHatipoglu, C.
dc.contributor.authorErdinc, S.
dc.contributor.authorTumturk, A.
dc.date.accessioned2021-03-05T12:06:34Z
dc.date.available2021-03-05T12:06:34Z
dc.date.issued2018
dc.identifier.citationAydin M., Ergonul O., Azap A., Bilgin H., Aydin G., Cavus S. A. , Demiroglu Y. Z. , Aliskan H. E. , Memikoglu O., Menekse S., et al., "Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections.", The Journal of hospital infection, cilt.98, ss.260-263, 2018
dc.identifier.issn0195-6701
dc.identifier.othervv_1032021
dc.identifier.otherav_ab7c5969-3040-48d0-b2ec-a652bdd57beb
dc.identifier.urihttp://hdl.handle.net/20.500.12627/114485
dc.identifier.urihttps://doi.org/10.1016/j.jhin.2017.11.014
dc.description.abstractThis article describes the emergence of resistance and predictors of fatality for 1556 cases of healthcare-associated Gram-negative bloodstream infection in 2014 and 2015. The colistin resistance rate in Klebsiella pneumoniae was 16.1%, compared with 6% in 2013. In total, 660 (42.4%) cases were fatal. The highest fatality rate was among patients with Acinetobacter baumannii bacteraemia (58%), followed by Pseudomonas aeruginosa (45%), Klebsiella pneumoniae (41%), Enterobacter cloacae (32%) and Escherichia coli (28%). On multi-variate analysis, the minimum inhibitory concentrations for carbapenems [odds ratio (OR) 1.02, 95% confidence interval (CI) 1.01-1.04; P = 0.002] and colistin (OR 1.1, 95% CI 1.03-1.17; P = 0.001) were found to be significantly associated with fatality. (C) 2017 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
dc.language.isoeng
dc.subjectSosyoloji
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectSosyal Bilimler Genel
dc.subjectSosyal Bilimler (SOC)
dc.subjectBULAŞICI HASTALIKLAR
dc.subjectİmmünoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectSosyal ve Beşeri Bilimler
dc.subjectKAMU, ÇEVRE VE İŞ SAĞLIĞI
dc.titleRapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections.
dc.typeMakale
dc.relation.journalThe Journal of hospital infection
dc.contributor.departmentBaşkent Üniversitesi , ,
dc.identifier.volume98
dc.identifier.issue3
dc.identifier.startpage260
dc.identifier.endpage263
dc.contributor.firstauthorID252193


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster